Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Tetrahydrozoline Hcl
Brand Name
Harris Teeter Eye Drops Original
Generic Name
Tetrahydrozoline Hcl
Active Ingredient
TetrahydrozolineCategory
Plasma Volume Expander [EPC]
Salt Form
Hydrochloride
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| .05 g/100mL | SOLUTION/ DROPS | OPHTHALMIC | 69256-977 |
Detailed information about Harris Teeter Eye Drops Original
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Harris Teeter Eye Drops Original, you must consult a qualified healthcare professional.
Tetrahydrozoline is an alpha-adrenergic agonist used primarily as a topical decongestant to relieve eye redness and nasal congestion. It works by constricting blood vessels in the affected areas to reduce swelling and irritation.
For the treatment of minor ocular irritation and redness, the standard adult dosage is:
For nasal congestion, the standard adult dosage is:
Tetrahydrozoline must be used with extreme caution in children. According to the American Academy of Pediatrics and FDA guidelines:
Specific dosage adjustments for patients with kidney disease have not been established for topical Tetrahydrozoline. However, because systemic absorption is low when used correctly, standard dosing is typically used. Patients with severe renal failure should still consult their doctor before use.
No specific adjustments are required for patients with liver disease under normal topical usage. If systemic toxicity is suspected, the clearance of the drug may be delayed in those with significant hepatic dysfunction.
Geriatric patients may be more sensitive to the effects of sympathomimetic amines. While no specific dose reduction is mandated, elderly patients should use the lowest effective dose and monitor for increases in blood pressure or heart rate.
Storage: Store at room temperature (15°C to 30°C / 59°F to 86°F) away from moisture and heat. Keep the bottle tightly closed.
If you miss a dose, use it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular timing. Do not double the dose to catch up.
An overdose of Tetrahydrozoline, particularly through oral ingestion, is a medical emergency. Signs of overdose include:
In the event of accidental ingestion, contact a Poison Control Center (1-800-222-1222 in the US) or seek emergency medical care immediately.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or use the product for longer than 3 days without medical guidance.
Most patients tolerate Tetrahydrozoline well when used as directed for short periods. However, common localized reactions include:
> Warning: Stop taking Tetrahydrozoline and call your doctor immediately if you experience any of these.
The most significant long-term risk of Tetrahydrozoline is the development of "conjunctivitis medicamentosa" or "rhinitis medicamentosa." This is a condition where the tissues of the eye or nose become physically dependent on the vasoconstrictor to maintain normal vessel tone. Over time, the tissue may become thickened (hypertrophic), and the redness or congestion may become permanent and resistant to treatment. Long-term use can also mask underlying medical conditions, such as chronic dry eye syndrome or allergic fungal sinusitis, which require different therapeutic approaches.
No FDA black box warnings are currently issued for Tetrahydrozoline. However, the FDA has issued multiple safety communications regarding the risk of serious harm or death if Tetrahydrozoline is ingested by children. The packaging for these products is required to be child-resistant under the Poison Prevention Packaging Act.
Report any unusual symptoms to your healthcare provider. You may also report side effects to the FDA at 1-800-FDA-1088.
Tetrahydrozoline is intended for temporary relief only. It is not a cure for eye or nasal conditions. Patients should be aware that the most common cause of treatment failure is the development of rebound congestion due to overuse. Never share your eye drops or nasal sprays with others, as this can spread infection.
No FDA black box warnings for Tetrahydrozoline. However, the risk of pediatric toxicity via oral ingestion is considered a major public health concern.
For standard OTC use, specific lab tests are not required. However, if a patient is using the drug under medical supervision for an extended period, the following may be monitored:
Tetrahydrozoline may cause temporary blurred vision or light sensitivity (due to pupil dilation). Patients should wait until their vision is clear before driving or operating heavy machinery. If systemic absorption causes dizziness or drowsiness, these activities should be avoided entirely.
There is no direct chemical interaction between alcohol and topical Tetrahydrozoline. However, alcohol can cause vasodilation (widening of blood vessels), which may counteract the effects of the drug and worsen eye redness or nasal congestion. Furthermore, if systemic toxicity occurs, alcohol may exacerbate CNS depression.
If you have used Tetrahydrozoline for longer than the recommended 3 days, do not stop abruptly if you experience severe rebound congestion. Instead, consult a doctor. They may recommend a tapering schedule or the use of a topical corticosteroid to help reduce the inflammation caused by the withdrawal of the vasoconstrictor.
> Important: Discuss all your medical conditions with your healthcare provider before starting Tetrahydrozoline, especially if you have a history of heart problems or glaucoma.
Tetrahydrozoline is not known to significantly interfere with common blood or urine laboratory tests. However, its effect on pupil size may interfere with certain ophthalmic diagnostic tests (such as retinal photography or glaucoma screening) if used immediately before an eye exam.
Most interactions with Tetrahydrozoline are pharmacodynamic, meaning the drugs have additive or opposing effects on the same physiological systems (the sympathetic nervous system). The primary concern is the additive effect on blood pressure and heart rate.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those applied to the skin or eyes.
Tetrahydrozoline must NEVER be used in the following circumstances:
Healthcare providers must weigh the risks and benefits in patients with:
Patients who have had allergic reactions to other imidazoline derivatives (such as oxymetazoline, naphazoline, or xylometazoline) are at a higher risk of being allergic to Tetrahydrozoline. If you have reacted to other "redness relief" eye drops or long-acting nasal sprays, consult an allergist before using Tetrahydrozoline.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing or recommending Tetrahydrozoline to ensure it is safe for your specific health profile.
FDA Pregnancy Category C: Animal reproduction studies have not been conducted with Tetrahydrozoline. It is also not known whether Tetrahydrozoline can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.
It is not known whether Tetrahydrozoline is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from sympathomimetic amines, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Given its short-term use, most providers suggest avoiding it while breastfeeding to prevent any risk of the infant experiencing tachycardia or irritability.
Tetrahydrozoline is particularly dangerous to the pediatric population.
In patients over 65, the risk of systemic side effects is increased.
While systemic absorption is minimal, the kidneys are the primary route of elimination for any absorbed drug. Patients with end-stage renal disease (ESRD) should be monitored for signs of systemic toxicity, although no specific dose adjustments are provided by manufacturers.
There are no specific guidelines for Tetrahydrozoline use in patients with liver impairment. However, as with renal impairment, clinicians should be alert for signs of prolonged drug effect if systemic absorption occurs in patients with severe cirrhosis (Child-Pugh Class C).
> Important: Special populations require individualized medical assessment. Always consult a pediatrician before giving this medication to a child and inform your doctor if you are pregnant or nursing.
Tetrahydrozoline is a sympathomimetic agent that primarily targets alpha-adrenergic receptors. It is a derivative of imidazoline. Its primary molecular action is as an agonist at alpha-1 adrenoceptors located on the vascular smooth muscle cells of the conjunctival and nasal mucosal blood vessels.
Upon binding to these receptors, Tetrahydrozoline activates the Gq protein-coupled signaling pathway, leading to the activation of phospholipase C. This results in an increase in intracellular calcium levels, which triggers the contraction of the smooth muscle fibers. This contraction narrows the lumen of the blood vessels (vasoconstriction), thereby reducing the physical diameter of the vessels and decreasing the amount of fluid that can leak into surrounding tissues. This effectively reduces redness and edema.
| Parameter | Value |
|---|---|
| Bioavailability | Low (Topical); High (Oral/Ingested) |
| Protein Binding | Not characterized in humans |
| Half-life | ~2 to 4 hours (systemic) |
| Tmax | <1 hour (systemic absorption) |
| Metabolism | Hepatic (minimal if used topically) |
| Excretion | Renal |
Tetrahydrozoline is classified as an Alpha-Adrenergic Agonist and a Topical Decongestant. Within the EphMRA anatomical classification, it is categorized under S01GA02 (Ophthalmologicals, Decongestants). It is related to other sympathomimetics but is distinct in its preference for topical application over systemic (oral) use due to its potent CNS effects if absorbed systemically.
Common questions about Harris Teeter Eye Drops Original
Tetrahydrozoline is primarily used for the temporary relief of eye redness and nasal congestion. In the eyes, it works by narrowing swollen blood vessels caused by minor irritants like dust, smoke, or swimming. For the nose, it acts as a decongestant to relieve stuffiness associated with the common cold or allergies. It is an over-the-counter medication intended for short-term symptomatic relief. It does not treat underlying infections or chronic conditions.
The most common side effects include a temporary stinging or burning sensation in the eyes or nose immediately after use. Some users may experience blurred vision for a few minutes after applying eye drops. Sneezing and nasal dryness are also frequently reported with the nasal spray. If used for more than three days, a 'rebound' effect can occur, where redness or congestion becomes worse than before. Most minor side effects disappear quickly once the medication is stopped.
While there is no direct contraindication between alcohol and topical Tetrahydrozoline, caution is advised. Alcohol can cause blood vessels to dilate, which may counteract the redness-relieving effects of the drug in the eyes. Additionally, if the drug is accidentally absorbed systemically, alcohol could potentially increase the risk of dizziness or drowsiness. For the best results, it is recommended to limit alcohol use while treating eye or nasal irritation. Always consult your doctor if you have concerns about alcohol and your medications.
Tetrahydrozoline is classified as FDA Pregnancy Category C, meaning its safety has not been fully established in human studies. It should only be used during pregnancy if clearly needed and recommended by a healthcare provider. Many doctors suggest using saline eye drops or nasal sprays as safer alternatives for pregnant women. Systemic absorption, though low, could theoretically affect blood flow, so short-term use is essential. Always discuss the risks and benefits with your obstetrician before use.
Tetrahydrozoline is known for its very rapid onset of action, typically working within 1 to 5 minutes after application. In the eye, you will notice a visible reduction in redness almost immediately as the blood vessels constrict. For nasal use, the decongestant effect usually peaks within 15 to 30 minutes, making it easier to breathe. The effects generally last between 4 and 8 hours. If symptoms do not improve within this timeframe, it may indicate a more serious underlying condition.
If you have only used Tetrahydrozoline for the recommended 1 to 3 days, you can stop taking it suddenly without any issues. However, if you have overused the medication for an extended period, you may experience 'rebound' congestion or redness upon stopping. This occurs because the blood vessels have become dependent on the drug to stay constricted. In such cases, it is best to consult a doctor, who may suggest a gradual reduction or a different type of medication to help your tissues recover. Never use the product for more than 72 hours without medical advice.
If you miss a dose of Tetrahydrozoline, use it as soon as you remember, provided you still need the symptom relief. However, if it is nearly time for your next scheduled dose, you should skip the missed one and continue with your regular schedule. Do not apply extra drops or sprays to make up for a missed dose, as this increases the risk of side effects and rebound symptoms. Since this medication is often used 'as needed,' missing a dose is generally not a significant concern. Always follow the frequency limits on the product label.
There is no clinical evidence to suggest that Tetrahydrozoline causes weight gain. Because it is applied topically to the eyes or nose and has very low systemic absorption when used correctly, it does not affect metabolic processes or appetite. Weight gain is not listed as a side effect in the FDA-approved prescribing information for any Tetrahydrozoline products. If you experience unexplained weight gain while using any medication, you should consult your healthcare provider to identify the underlying cause. It is likely unrelated to this specific decongestant.
Tetrahydrozoline can interact with certain medications, most notably Monoamine Oxidase Inhibitors (MAOIs) and tricyclic antidepressants. Taking these together can lead to a dangerous increase in blood pressure. You should also be cautious when using other decongestants or medications that affect the heart and blood pressure. Always inform your doctor or pharmacist of all medications you are using, including other eye drops or nasal sprays. This helps prevent potentially serious drug-drug interactions.
Yes, Tetrahydrozoline is widely available as a generic medication and is often sold under various store brands as 'Redness Relief' or 'Original Decongestant' drops. Generic versions are required by the FDA to have the same active ingredient and strength as the brand-name products (such as Visine). They are generally more cost-effective while providing the same level of symptomatic relief. When buying generic, always check the inactive ingredients if you have sensitivities to specific preservatives like benzalkonium chloride.
Other drugs with the same active ingredient (Tetrahydrozoline)